CRIS

Curis

• TipRanks·18h ago

  Curis Shareholders Approve Expanded Capital Structure and Governance

• PUBT·19h ago

  Curis shareholders approve authorized common stock increase at annual meeting

• TipRanks·05/15 14:12

  Why Is Vanguard Total Stock Market (VTI) ETF Falling Today, 5/15/26?

• TipRanks·05/14 15:54

  Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/14/26?

• TipRanks·05/14 00:24

  Curis Inc. Earnings Call Highlights Clinical Momentum

• TipRanks·05/13 14:54

  Why Is Vanguard Total Stock Market (VTI) ETF Up Today, 5/13/26?

• TipRanks·05/13 13:55

  Curis Reaffirmed at Buy as Analyst Maintains $5 Price Target on Emavusertib Clinical Catalysts in CLL and PCNSL

• TipRanks·05/13 10:25

  Curis Buy Rating Reiterated as Analyst Highlights Dual-Blockade Progress and Clinical Catalysts; $17 Price Target Maintained

• Seeking Alpha·05/13 08:21

  Curis anticipates TakeAim CLL initial 5-patient dosing by mid-2026 while projecting cash runway into second half of '27

• TipRanks·05/12 22:10

  Curis reports Q1 EPS ($1.25), consensus (29c)

• TipRanks·05/12 22:07

  Curis sees cash and proceeds enough for operations into second half of FY27

• Benzinga·05/12 22:00

  Curis Reports Q1 2026 Results: Full Earnings Call Transcript

• Reuters·05/12 20:11

  Curis Q1 operating loss widens as expenses rise

• Benzinga·05/12 20:01

  Curis Q1 EPS $(1.25) Misses $(0.40) Estimate

• Seeking Alpha·05/12 20:01

  Curis GAAP EPS of -$1.25 misses by $0.90